Rosiglitazone-Containing Diabetes Medicines

The FDA has relaxed the 2010 restrictions on Rosiglitazone-containing diabetes medications, including Avandia, Avandamet, Avandaryl, and generics, because further study has indicated no increased risk of heart attack relative to other diabetes medications.  For details see http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm376683.htm.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s